Qiagen NV (QGEN)
42.34
-1.01
(-2.33%)
USD |
NYSE |
Jun 14, 16:00
42.34
0.00 (0.00%)
Pre-Market: 20:00
Qiagen Cash and Short Term Investments (Quarterly): 893.13M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 893.13M |
| December 31, 2023 | 1.058B |
| September 30, 2023 | 1.016B |
| June 30, 2023 | 1.332B |
| March 31, 2023 | 1.287B |
| December 31, 2022 | 1.418B |
| September 30, 2022 | 1.887B |
| June 30, 2022 | 1.311B |
| March 31, 2022 | 1.230B |
| December 31, 2021 | 1.065B |
| September 30, 2021 | 957.32M |
| June 30, 2021 | 898.02M |
| March 31, 2021 | 791.73M |
| December 31, 2020 | 715.23M |
| September 30, 2020 | 501.95M |
| June 30, 2020 | 744.24M |
| March 31, 2020 | 744.68M |
| December 31, 2019 | 753.23M |
| September 30, 2019 | 799.18M |
| June 30, 2019 | 785.96M |
| March 31, 2019 | 780.39M |
| December 31, 2018 | 1.394B |
| September 30, 2018 | 920.73M |
| June 30, 2018 | 900.19M |
| March 31, 2018 | 1.014B |
| Date | Value |
|---|---|
| December 31, 2017 | 1.017B |
| September 30, 2017 | 974.95M |
| June 30, 2017 | 608.85M |
| March 31, 2017 | 273.39M |
| December 31, 2016 | 532.18M |
| September 30, 2016 | 464.34M |
| June 30, 2016 | 406.44M |
| March 31, 2016 | 447.26M |
| December 31, 2015 | 420.83M |
| September 30, 2015 | 429.53M |
| June 30, 2015 | 367.55M |
| March 31, 2015 | 392.29M |
| December 31, 2014 | 576.70M |
| September 30, 2014 | 692.02M |
| June 30, 2014 | 654.77M |
| March 31, 2014 | 677.97M |
| December 31, 2013 | 380.23M |
| September 30, 2013 | 355.75M |
| June 30, 2013 | 373.20M |
| March 31, 2013 | 460.54M |
| December 31, 2012 | 484.49M |
| September 30, 2012 | 311.31M |
| June 30, 2012 | 266.33M |
| March 31, 2012 | 275.36M |
| December 31, 2011 | 275.71M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
501.95M
Minimum
Sep 2020
1.887B
Maximum
Sep 2022
1.009B
Average
927.67M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| MoonLake Immunotherapeutics | 547.05M |
| LENZ Therapeutics Inc | 213.28M |
| Thermo Fisher Scientific Inc | 7.25B |
| argenx SE | -- |
| uniQure NV | 555.68M |